This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
End-To-End Support at Every Stage of Your Drug Development Journey
Brochures, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions
Towards A New Standard of Care with Aptar Pharma’s Digital Health
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions
Aptar Pharma discusses an antibody nasal spray for SARS-CoV-2
Publications, Pharmaceutical, Innovation & Insights, Product Solutions
Delivering On The Promises of Intranasal Vaccination
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
